We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
Cap. Flow
+$263M
Cap. Flow %
4.63%
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$35.7M
2
MRK icon
Merck
MRK
+$30.3M
3
MSFT icon
Microsoft
MSFT
+$22.4M
4
YUMC icon
Yum China
YUMC
+$17.6M
5
OXY icon
Occidental Petroleum
OXY
+$17.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$36.5M
2
INTC icon
Intel
INTC
+$32.4M
3
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
+$17.1M
4
NVR icon
NVR
NVR
+$16.3M
5
DE icon
Deere & Co
DE
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Financials 17.92%
3 Industrials 13.48%
4 Consumer Discretionary 11.28%
5 Healthcare 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVSB icon
951
Riverview Bancorp
RVSB
$107M
$104K ﹤0.01%
+12,000
New +$106K
SCX
952
DELISTED
The L.S. Starrett Company
SCX
$99K ﹤0.01%
11,540
-3,376
-23% -$28.5K
LFVN icon
953
LifeVantage
LFVN
$82.4M
$95K ﹤0.01%
19,952
-200
-1% -$1.05K
WG
954
DELISTED
Willbros Group
WG
$95K ﹤0.01%
66,803
+35,100
+111% +$73.5K
PVLA
955
Palvella Therapeutics
PVLA
$1.98B
$93K ﹤0.01%
+154
New +$71.6K
NH
956
DELISTED
NantHealth, Inc
NH
$87K ﹤0.01%
+1,902
New +$101K
AGRX
957
DELISTED
Agile Therapeutics
AGRX
$86K ﹤0.01%
+16
New +$149K
SYRE icon
958
Spyre Therapeutics
SYRE
$8.87B
$85K ﹤0.01%
+628
New +$76.8K
PKD
959
DELISTED
Parker Drilling Company
PKD
$80K ﹤0.01%
5,331
+4,077
+325% +$63K
PCTI
960
DELISTED
PCTEL, Inc. Common Stock
PCTI
$79K ﹤0.01%
10,761
-13,195
-55% -$93.1K
EPE
961
DELISTED
EP Energy Corporation
EPE
$72K ﹤0.01%
+30,300
New +$72.4K
IPAS
962
DELISTED
Ipass Inc Common Stock
IPAS
$69K ﹤0.01%
+13,290
New +$80.9K
SREV
963
DELISTED
ServiceSource International, Inc.
SREV
$68K ﹤0.01%
22,100
+6,300
+40% +$20.3K
VIRX
964
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$61K ﹤0.01%
+472
New +$44.2K
XRM
965
DELISTED
Xerium Technologies Inc (new)
XRM
$59K ﹤0.01%
13,930
+2,252
+19% +$9.89K
MR
966
DELISTED
Montage Resources Corporation Common Stock
MR
$55K ﹤0.01%
+1,533
New +$55.4K
AGTC
967
DELISTED
Applied Genetic Technologies Corporation
AGTC
$50K ﹤0.01%
+14,000
New +$52.9K
TOVX icon
968
Theriva Biologics
TOVX
$10.2M
$49K ﹤0.01%
11
– –
DALN
969
DELISTED
DallasNews
DALN
$48K ﹤0.01%
2,511
– –
PRTS icon
970
CarParts.com
PRTS
$42.8M
$42K ﹤0.01%
1,686
-4,377
-72% -$109K
ADXS
971
DELISTED
Advaxis Inc
ADXS
$37K ﹤0.01%
+880
New +$44.5K
VYNT
972
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$31K ﹤0.01%
110
-158
-59% -$60.3K
DNR
973
DELISTED
Denbury Resources, Inc.
DNR
$22K ﹤0.01%
+10,000
New +$15.7K
HHS icon
974
Harte-Hanks
HHS
$17.7M
$12K ﹤0.01%
+1,260
New +$12.7K
A icon
975
Agilent Technologies
A
$39.1B
– –
-17,910
Closed -$1.15M
37 38
39
40 41

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.

  • Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
  • Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
  • Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
  • Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
  • Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
  • Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.